why choose us

First received: November 03, 2023

Clinical Trial: Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Lung Cancer Diagnosis

Study Type: OBSERVATIONAL


Official Title: The PROACT LUNG Study: A Prospective, Observational,Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening (FRNM-007)

Brief Summary: The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from high-risk participants who will undergo a routine, standard-of-care screening Low-Dose Computed Tomography (LDCT).

Read more